Jacob Plieth Edwin Elmhirst It took nearly two decades from the start of tremelimumab’s first-in-human study until Astrazeneca saw the drug approved last week as Imjudo. This is undoubtedly a lesson in perseverance, but it does not in fact represent the longest development period of a drug from phase 1 to US approval. That honour,...
Chemists find new way of creating the building blocks of many drugs OHIO STATE UNIVERSITY COLUMBUS, Ohio – Organic chemists at The Ohio State University have figured out how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs – including one most commonly used to...
Researchers at The University of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety or effectiveness. The findings are currently available in EBioMedicine. Credit: University of Texas Medical Branch at Galveston Vaccines are the...
The recent decision of a Saskatchewan judge to reject the proposed settlement between the provinces and Purdue Pharma, the maker of OxyContin, should raise serious questions. Purdue introduced the prescription drug oxycontin in 1996 and marketed it as safer and less addictive than other opioids. This is now seen by many as the beginning of the opioid crisis...
